| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 06/05/2002 | CN1352650A Recombinant IL-18 antagonist useful in treatment of IL-18 mediated disorders |
| 06/05/2002 | CN1351888A Method for producing anti-osteopontic antibody medicine and use |
| 06/04/2002 | US6399856 Reversible nuclear genetic system for male sterility in transgenic plants |
| 06/04/2002 | US6399763 Method for producing antibody fragments |
| 06/04/2002 | US6399762 Methods and compositions for diagnosing and treating chromosome -18p related disorders |
| 06/04/2002 | US6399758 Nucleic acid encoding a glycosyltransferase of porcine origin useful in decreasing unwanted carbohydrate epitopes in cells by having a higher affinity for the substrate than a second glycosyl transferase; use in xenotransplantation |
| 06/04/2002 | US6399745 Use of leptin antagonists for treating insulin resistance in type II diabetes |
| 06/04/2002 | US6399743 Isolation and characterization of a rat epidermal growth factor related protein |
| 06/04/2002 | US6399588 Cancer treatment method utilizing plasmids suitable for IL-2 expression |
| 06/04/2002 | US6399573 Interleukin-1 receptor antagonist beta (IL-1rabeta) |
| 06/04/2002 | US6399571 Polypeptides |
| 06/04/2002 | US6399567 Cyclic hexapeptides having antibiotic activity |
| 06/04/2002 | US6399376 Modulation of vascular cell adhesive molecule expression through oligonucleotide interactions |
| 06/04/2002 | US6399368 A genetically engineered cloning vector containing a inducible promoter, leader sequence and a soluble t-cell receptor variable domain; therapy for autoimmune diseases and cancer |
| 06/04/2002 | US6399350 Screening for modulators by exposing kuz polypeptide to protease substrate in presence of modulating agent which can be an antibody, dominant negative fragment of the polypeptide or enzyme inhibitor |
| 06/04/2002 | US6399345 Subunits of NADH dehydrogenase |
| 06/04/2002 | US6399336 Practical in vitro sialylation of recombinant glycoproteins |
| 06/04/2002 | US6399333 Process for producing erythropoietin containing no animal proteins |
| 06/04/2002 | US6399331 Method for culturing recombinant cells |
| 06/04/2002 | US6399330 Nucleotide and amino acid sequences of crystal/insecticidal proteins; active against japanese beetle and red flour beetle; biological pest control |
| 06/04/2002 | US6399328 Amino acid sequence; hybridization probes; amplification primers; anticarcinogenic agents; antitumor agents |
| 06/04/2002 | US6399323 Method of preparing polypeptides in a cell-free translation system |
| 06/04/2002 | US6399315 Drug screening by contacting cells transfected with nucleic acid encoding a g-protein coupled receptor which binds corticotropin-releasing factor, then monitoring cell for compounds which bind the receptor |
| 06/04/2002 | US6399294 Probes; primers; immunogens; for diagnosis of human immunodeficiency virus infections |
| 06/04/2002 | US6399067 Methods and compositions for impairing multiplication of HIV-1 |
| 06/04/2002 | US6399066 Capsular polysaccharide adhesin antigen, preparation, purification and use |
| 06/04/2002 | US6399065 Methods for modulating SLAM-expressing T cells |
| 06/04/2002 | US6399063 Monoclonal antibodies directed to the HER2 receptor |
| 06/04/2002 | US6399061 Monoclonal secreted by atcc deposit no. hb11388 and transfectoma tcae8 accorded atcc deposit no. 69119; parenteral injection |
| 06/04/2002 | US6399060 Composition having nematicidal activity |
| 06/04/2002 | US6399053 Methods of enhancing bioactivity of chemokines |
| 06/04/2002 | CA2361950A1 Antibiotics g 23077, pharmaceutically acceptable salts and compositions, and use thereof |
| 06/04/2002 | CA2171424C Acylated insulin |
| 06/04/2002 | CA2011450C Recombinant b-chain of the il-2 receptor |
| 06/04/2002 | CA1341364C Single polypeptide chain binding molecules |
| 05/30/2002 | WO2002042777A2 Modulation of the interaction between evh1 domains |
| 05/30/2002 | WO2002042480A2 Modified vaccinia ankara virus variant |
| 05/30/2002 | WO2002042462A2 Therapeutic agents and methods of use thereof for treating an amyloidogenic disease |
| 05/30/2002 | WO2002042456A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 05/30/2002 | WO2002042455A2 Modifier of organelle metalbolism |
| 05/30/2002 | WO2002042448A1 Novel polypeptide |
| 05/30/2002 | WO2002042444A2 Fungal gene cluster associated with pathogenesis |
| 05/30/2002 | WO2002042336A2 Fgf-affinity chromatography |
| 05/30/2002 | WO2002042333A1 Anti-cd14 monoclonal antibody having effect of inhibiting cd14/tlr binding |
| 05/30/2002 | WO2002042330A2 Cystoskeleton-associated proteins |
| 05/30/2002 | WO2002042326A1 A method of expression and agents identified thereby |
| 05/30/2002 | WO2002042324A1 Gene encoding protein cluster i and the encoded protein |
| 05/30/2002 | WO2002022782A3 Homologous 28-kilodalton immunodominant protein genes of ehrlichia canis and uses thereof |
| 05/30/2002 | WO2002020736A9 Proteases |
| 05/30/2002 | WO2002018581A9 G-protein coupled receptors |
| 05/30/2002 | WO2002002738A3 Host cells containing multiple integrating vectors |
| 05/30/2002 | WO2001096577A8 Production of secreted polypeptides |
| 05/30/2002 | WO2001087330A3 Compositions and methods for achieving immune suppression |
| 05/30/2002 | WO2001081413A3 Isolated human transporter proteins, nucleic acids and uses thereof |
| 05/30/2002 | WO2001068888A3 Production of chimeric capsid vectors |
| 05/30/2002 | WO2001068704A3 G-protein coupled receptors |
| 05/30/2002 | WO2001066746A3 G-protein coupled receptor related polypeptides |
| 05/30/2002 | WO2001064877A3 Human schizophrenia gene |
| 05/30/2002 | WO2001029063A8 Death domain-containing receptor polynucleotides, polypeptides, and antibodies |
| 05/30/2002 | WO2000078952A8 Human rna metabolism proteins (rmep) |
| 05/30/2002 | US20020065408 Generating heterologous proteins in eukaryotic cells; obtain cell, transform, express vector, recover heterologous protein |
| 05/30/2002 | US20020065398 Humanized and chimeric monoclonal antibodies that recognize epidermal growth factor receptor (egf-r); diagnostic and therapeutic use |
| 05/30/2002 | US20020065395 Polypeptide for use as diagnostic tool in screening bactericides |
| 05/30/2002 | US20020065393 Human hypoxanthine- (guanine) phosphoribosy1 transferase-2 |
| 05/30/2002 | US20020065392 Methods for production of protein |
| 05/30/2002 | US20020065238 EPO primary response gene, EPRG3pt |
| 05/30/2002 | US20020065237 SBHWSB1 polypeptides/polynucleotides produced by recombinant techniques; gene therapy; diagnostic tests; agonists; antagonists; "positional cloning"; sequence of Serine(S), Aspargine/Asparic Acid(W), Histidine (H) and Tryptophan (T) |
| 05/30/2002 | US20020065220 For use in diagnosis and therapy of disorders treating disorders related to these novel human immunoglobulin-like (Ig- like) proteins |
| 05/30/2002 | US20020065210 DcR3 polypeptide, a TNFR homolog |
| 05/30/2002 | US20020064872 Polypeptide for use in the detection and prevention of tumors; antitumor agents; anticarcinogenic agents |
| 05/30/2002 | US20020064865 Crystal protein for use in bological pest control |
| 05/30/2002 | US20020064858 Compositions including glycosaminoglycans degrading enzymes and use of same against surface protected bacteria |
| 05/30/2002 | US20020064848 Novel histidinol dehydrogenase |
| 05/30/2002 | US20020064846 Protein for use treatment of diabetes |
| 05/30/2002 | US20020064843 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 05/30/2002 | US20020064835 Generating muscle protein; obtain sample, incubate under reducing environment, recover muscle protein |
| 05/30/2002 | US20020064834 Microbiological production method for alpha-L-aspartyl-L-phenylalanine |
| 05/30/2002 | US20020064826 Cytokine receptor-like polynucleotides, polypeptides, and antibodies |
| 05/30/2002 | US20020064823 Nucleotide sequences which code binding protein for use in human therapeutics and gene therapy |
| 05/30/2002 | US20020064821 Isolated human ion channel proteins, nucleic acid molecules encoding human ion channel proteins, and uses thereof |
| 05/30/2002 | US20020064818 Nucleotide sequences coding preferential polypeptide; for use in diagnosis and treatment of cancer, nervous system, inflammatory and immunological disorders |
| 05/30/2002 | US20020064812 Plasmid for use in the treatment of blood disorders |
| 05/30/2002 | US20020064786 Cancer diagnosis and therapy based on mutations in TGF-beta receptors |
| 05/30/2002 | US20020064536 Immobilizing a mammal by administering the toxin with a polysaccharide stabilizer, nonimmunogenic; use after surgery such as hip displasia or to recover from leg injuries in domestic animals |
| 05/30/2002 | US20020064535 Such as human granulocytic ehrlichiosis; polypeptides of antigenic portion(s) of an Ehrlichia antigen and DNA sequences encoding them; vaccines; detection kits |
| 05/30/2002 | US20020064534 Herpesvirus preparations and their uses |
| 05/30/2002 | CA2429712A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 05/30/2002 | CA2429576A1 Fungal gene cluster associated with pathogenesis |
| 05/30/2002 | CA2429467A1 Anti-cd14 monoclonal antibody having effect of inhibiting cd14/tlr binding |
| 05/30/2002 | CA2426939A1 Cystoskeleton-associated proteins |
| 05/30/2002 | CA2421151A1 Modified vaccinia ankara virus variant |
| 05/29/2002 | EP1209240A1 Novel compound f-15078 |
| 05/29/2002 | EP1209230A1 MODIFIED cDNA OF RAT bcl-x GENE AND MODIFIED PROTEIN |
| 05/29/2002 | EP1209167A1 Method of producing a biosensor protein capable of regulating a fluorescence property of the modified green fluorescent protein therein, and the biosensor protein produced by the method |
| 05/29/2002 | EP1208380A2 Cancer associated antigens and uses therefor |
| 05/29/2002 | EP1208235A1 Abc transport polynucleotides, polypeptides, and antibodies |
| 05/29/2002 | EP1208207A2 Method for producing a channel-forming protein |
| 05/29/2002 | EP1208202A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 05/29/2002 | EP1208201A2 Compositions and methods for the treatment of immune related diseases |
| 05/29/2002 | EP1208199A2 DNA CODING FOR $g(b)-TUBULIN AND USE THEREOF |